TIPE or TNFAIP8 |
Tumor necrosis factor-α-induced protein 8 |
TIPE1 |
Tumor necrosis factor-α-induced protein 8-like 1 |
TIPE2 |
Tumor necrosis factor-α-induced protein 8-like 2 |
TIPE3 |
Tumor necrosis factor-α-induced protein 8-like 3 |
TLR |
Toll-like receptor |
TNF-α |
Tumor necrosis factor-α |
FLIP |
Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein |
mTOR |
Mammalian target of rapamycin |
NF-κB |
Nuclear factor κ-light-chain-enhancer of activated B cells |
MAPK |
Mitogen-activated protein kinase |
MMP |
Matrix metalloproteinase |
VEGF |
Vascular endothelial growth factor |
DLBCL |
Diffuse large B-cell lymphoma |
EMT |
Epithelial-to-mesenchymal transition |
EC |
Endometrial carcinoma |
ESCC |
Esophageal squamous cell carcinoma |
ERK1/2 |
Extracellular signal-regulated kinase 1/2 |
HCC |
Hepatocellular carcinoma |
NHL |
Non-Hodgkin’s lymphoma |
PTCL |
Peripheral T-cell lymphoma |
NSCLC |
Non-small cell lung cancer |
OS |
Osteosarcoma |
CNV |
Choroidal neovascularization |
T2DM |
Type 2 diabetes mellitus |
MG |
Myasthenia gravis |
HBV |
Hepatitis B virus |
HCV |
Hepatitis C virus |
AIH |
Autoimmune hepatitis |
AST |
Aspartate aminotransferase |
ALT |
Alanine aminotransferase |
PBMCs |
Peripheral blood mononuclear cells |
DSS |
Dextran sodium sulfate |
IL-6 |
Interleukin-6 |
Ox-LDL |
Oxidized low-density lipoprotein |
VSMCs |
Vascular smooth muscle cells |
SM-MHC |
Smooth muscle-myosin heavy chain |
SmαA |
Smooth muscle α-actin |
FLSs |
Fibroblast-like synoviocytes |
AA |
Adjuvant arthritis |
RPE |
Retinal pigment Epithelium |